United States· US:82576-080_e56ac6db-56ac-4d3d-8f56-5497bab115df
REZDIFFRA
A resmetirom product containing resmetirom, registered in United States by Madrigal Pharmaceuticals, Inc.. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Resmetirom is registered in 9 of 19 countries.
Countries holding a registration under ATC A05BA11 (resmetirom), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Resmetirom · ATC A05BA11
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RESMETIROM
- Manufacturer
- Madrigal Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- A05BA11
- ATC class
- Resmetirom
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 2, 2026
Packs & prices · 4
- ndc11825760803030 TABLET, COATED in 1 BOTTLE (82576-080-30)
- ndc11825760809090 TABLET, COATED in 1 BOTTLE (82576-080-90)
- ndc1182576-080-30
- ndc1182576-080-90
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Resmetirom in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaREZDIFFRAMadrigal Pharmaceuticals EU Limited, Dublin
- SpainREZDIFFRA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMadrigal Pharmaceuticals Eu Limited
- FinlandRezdiffraMadrigal Pharmaceuticals EU Limited
- FranceREZDIFFRA 100 mg, comprimé pelliculéMADRIGAL PHARMACEUTICALS EU (IRLANDE)
- BelgiumRezdiffra 100 mgMadrigal Pharmaceuticals EU
- IcelandRezdiffraMadrigal Pharmaceuticals EU Limited
- NetherlandsRezdiffra 100 mg filmomhulde tablettenMadrigal Pharmaceuticals EU Limited
- PolandRezdiffraMadrigal Pharmaceuticals EU Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afd8e741-d63c-44c9-9e5f-d271fcf9a320 GET /v1/drugs/afd8e741-d63c-44c9-9e5f-d271fcf9a320?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "80",
"substance": "RESMETIROM",
"productndc": "82576-080",
"dosage_form": "TABLET, COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA217785",
"marketing_category": "NDA"
}See everything about resmetirom.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.